J&J Pays $2M To Exit Idaho AG's Drug Pricing Suit
J&J is one of many drugmakers targeted over inflated AWPs in lawsuits brought by state attorneys general across the country. The attorneys general say their states' Medicaid programs used drugmakers' allegedly inflated AWPs to calculate how much to reimburse pharmacies for prescription drugs.
An Idaho state...
To view the full article, register now.